1. Home
  2. UTMD vs CRBU Comparison

UTMD vs CRBU Comparison

Compare UTMD & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Utah Medical Products Inc.

UTMD

Utah Medical Products Inc.

N/A

Current Price

$62.85

Market Cap

196.4M

Sector

Health Care

ML Signal

N/A

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

N/A

Current Price

$1.90

Market Cap

203.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UTMD
CRBU
Founded
1978
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.4M
203.9M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
UTMD
CRBU
Price
$62.85
$1.90
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
9.5K
1.3M
Earning Date
04-30-2026
06-08-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
3.64
EPS
2.68
N/A
Revenue
$40,903,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.48
P/E Ratio
$23.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$51.27
$0.66
52 Week High
$68.71
$3.53

Technical Indicators

Market Signals
Indicator
UTMD
CRBU
Relative Strength Index (RSI) 43.20 55.05
Support Level $60.00 $1.71
Resistance Level $64.21 $2.11
Average True Range (ATR) 1.67 0.15
MACD -0.61 0.00
Stochastic Oscillator 14.92 43.84

Price Performance

Historical Comparison
UTMD
CRBU

About UTMD Utah Medical Products Inc.

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: